Lixia Ding
Shanghai Jiao Tong University(CN)Shanghai Children's Medical Center(CN)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia(2019)293 cited
- → Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL(2015)179 cited
- → Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial(2022)89 cited
- → Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse(2021)47 cited
- → Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia(2019)37 cited
- → Functional analysis of Fanconi anemia mutations in China(2018)32 cited
- → Aurora Kinase A Regulates M1 Macrophage Polarization and Plays a Role in Experimental Autoimmune Encephalomyelitis(2014)28 cited
- → Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes(2017)28 cited
- → Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia(2020)26 cited
- → Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse(2021)16 cited